25.09
price up icon0.66%   0.1513
 
loading

Pfizer Inc 주식(PFE)의 최신 뉴스

pulisher
11:37 AM

Amgen and Pfizer appoint new Science executives - European Pharmaceutical Review

11:37 AM
pulisher
09:59 AM

Pfizer Inc. (NYSE:PFE) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat

09:59 AM
pulisher
09:56 AM

Pfizer Names New Head Of Research And Development - Baystreet.ca

09:56 AM
pulisher
09:35 AM

The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair - Zacks Investment Research

09:35 AM
pulisher
09:14 AM

Mizuho Securities USA LLC Sells 69,459 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat

09:14 AM
pulisher
08:30 AM

Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS? - Yahoo! Voices

08:30 AM
pulisher
08:15 AM

2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist - The Motley Fool

08:15 AM
pulisher
08:10 AM

Pfizer Inc. (NYSE:PFE) Shares Acquired by America First Investment Advisors LLC - MarketBeat

08:10 AM
pulisher
07:31 AM

Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU - Zacks Investment Research

07:31 AM
pulisher
07:11 AM

Pfizer Inc. (NYSE:PFE) Shares Sold by Intech Investment Management LLC - MarketBeat

07:11 AM
pulisher
07:00 AM

The Escalator: Pfizer, Eli Lilly, CVS Health and more - MM+M Online

07:00 AM
pulisher
06:22 AM

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) - BioSpace

06:22 AM
pulisher
06:07 AM

Ontario Teachers Pension Plan Board Has $1.12 Million Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat

06:07 AM
pulisher
04:31 AM

Pfizer elevates Chris Boshoff to top R&D role - pharmaphorum

04:31 AM
pulisher
04:28 AM

Mitochondrial-Based Therapeutics Market Key Players Analysis - openPR

04:28 AM
pulisher
04:00 AM

Zai Lab Partners with Pfizer to Commercialize Novel Antibiotic XACDURO in China | ZLAB Stock News - StockTitan

04:00 AM
pulisher
03:32 AM

EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia - Pharmaceutical Technology

03:32 AM
pulisher
Nov 20, 2024

Pfizer, Flynn Still Face Fines Over Epilepsy Drug Sale To NHS - Law360

Nov 20, 2024
pulisher
Nov 20, 2024

Meta, Pfizer on DOL List of Upcoming Contractor Anti-Bias Audits - Bloomberg Law

Nov 20, 2024
pulisher
Nov 20, 2024

Health Care Climbs as Obesity-Drug Makers ReboundHealth Care Roundup - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

How Pfizer is trying to make U.S. healthcare easier to navigate - Fast Company

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Picks Boshoff To Head R&D, A Smooth Transition In An Uncertain Time - Citeline News & Insights

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer (NYSE:PFE) Stock Price Down 0.6%Should You Sell? - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

EC approval for Pfizer’s Hympavzi - The Pharma Letter

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer promoted oncology chief Chris Boshoff to serve as CSO, R&D president - MM+M Online

Nov 20, 2024
pulisher
Nov 20, 2024

Flagship reveals new agreements under Pfizer link-up - The Pharma Letter

Nov 20, 2024
pulisher
Nov 20, 2024

Pzena Investment Management LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer, under pressure to change, names oncology head as new R&D chief - BioPharma Dive

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer names oncology head Chris Boshoff as R&D chief - Reuters

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Taps Cancer Chief to Lead Research, Find Hit Drugs - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Names New Chief Scientific Officer And President Of R&D - Contract Pharma

Nov 20, 2024
pulisher
Nov 20, 2024

Company veteran named chief scientific officer at Pfizer - ShareCast

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Shakes Up C-Suite, Elevating Cancer Chief Boshoff to CSO - BioSpace

Nov 20, 2024
pulisher
Nov 20, 2024

Chris Boshoff takes on new role at Pfizer - The Pharma Letter

Nov 20, 2024
pulisher
Nov 20, 2024

First Horizon Advisors Inc. Purchases 95,749 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer: Marketing authorization for Hympavzi in the EU - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer promotes oncology chief to lead R&D as activist Starboard circles - Financial Times

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer: new Chief Scientific Officer on January 1 - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer bags EU okay for haemophilia drug Hympavzi - pharmaphorum

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer names Chris Boshoff as new R&D chief starting 2025 - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer names head of oncology as new R&D chief - Seeking Alpha

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer names new chief scientific officer - baha news

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer taps insider as chief science officer amid pressure from activist Starboard - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Names New R&D Chief: Dr. Boshoff to Lead Scientific Innovation After 24 Drug Approvals | PFE Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Flagship, Pfizer alliance yields two more startup deals - BioPharma Dive

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer names Chris Boshoff as new R&D chief, WSJ reports - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer - PR Newswire

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer Names New R&D Chief - Yahoo! Voices

Nov 20, 2024
pulisher
Nov 20, 2024

Is It Time to Sell Eli Lilly and Pfizer Stocks? - Yahoo! Voices

Nov 20, 2024
pulisher
Nov 20, 2024

Pfizer's HYMPAVZI Wins EU Approval: First Weekly Treatment for Severe Hemophilia | PFE Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

StockNews.com Downgrades Pfizer (NYSE:PFE) to Buy - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Penicillin Drug Market: Comprehensive Analysis and Key Players-Pfizer, Inc., Novartis AG, Sanofi S.A - openPR

Nov 20, 2024
pulisher
Nov 20, 2024

UK Patent Win Over GSK Boosts Pfizer in Global RSV Vaccine Fight - BioSpace

Nov 20, 2024
pulisher
Nov 19, 2024

Pfizer Unit Can't Get $75M Left In Insider Trading Deal Fund - Law360

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules - Reuters

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer loses bid to recoup $75 million left over from SEC settlement - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer (NYSE:PFE) Trading Up 0.7%Here's What Happened - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer Inc. (NYSE:PFE) Holdings Lowered by PNC Financial Services Group Inc. - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Parnassus Investments LLC Increases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer Inc. (NYSE:PFE) Holdings Lowered by Banque Cantonale Vaudoise - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer (NYSE:PFE) stock falls 5.3% in past week as three-year earnings and shareholder returns continue downward trend - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Verity & Verity LLC Purchases 108,863 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Belmont Capital LLC Has $270,000 Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Pfizer Inc - Reuters

Nov 19, 2024
$290.00
price up icon 0.60%
drug_manufacturers_general SNY
$47.95
price up icon 0.37%
drug_manufacturers_general BMY
$58.09
price up icon 0.40%
drug_manufacturers_general NVS
$103.85
price up icon 0.72%
drug_manufacturers_general MRK
$99.47
price up icon 2.05%
자본화:     |  볼륨(24시간):